WallStreetZenWallStreetZen

NASDAQ: ORMP
Oramed Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their ORMP stock forecasts and price targets.

Forecast return on equity

Is ORMP forecast to generate an efficient return?

Company
-9.2%
Industry
28.43%
Market
296.37%
ORMP's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ORMP forecast to generate an efficient return on assets?

Company
-8.79%
Industry
14.81%
ORMP is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ORMP earnings per share forecast

What is ORMP's earnings per share in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.35

ORMP revenue forecast

What is ORMP's revenue in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$2.0M+2%

ORMP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ORMP$2.37N/AN/A
PTHS$32.00$50.00+56.25%Buy
PRLD$1.71$4.00+133.92%Buy
STRO$1.16$1.95+68.10%Hold
QNCX$1.79$6.00+235.20%Strong Buy
View Top Biotech Stocks

Oramed Pharmaceuticals Stock Forecast FAQ

What is ORMP's earnings growth forecast for 2025-2025?

(NASDAQ: ORMP) Oramed Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Oramed Pharmaceuticals's earnings in 2025 is -$24,218,000.

In 2025, ORMP is forecast to generate -$14,220,048 in earnings, with the lowest earnings forecast at -$13,662,400 and the highest earnings forecast at -$14,638,285.

If you're new to stock investing, here's how to buy Oramed Pharmaceuticals stock.

What is ORMP's revenue growth forecast for 2025-2025?

(NASDAQ: ORMP) Oramed Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Oramed Pharmaceuticals's revenue in 2025 is $2,000,000.

In 2025, ORMP is forecast to generate $83,647,344 in revenue, with the lowest revenue forecast at $80,367,056 and the highest revenue forecast at $86,107,560.

What is ORMP's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: ORMP) forecast ROA is -8.79%, which is lower than the forecast US Biotechnology industry average of 14.81%.

What is ORMP's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: ORMP) Oramed Pharmaceuticals's current Earnings Per Share (EPS) is -$0.61. In 2025, ORMP's EPS is forecast to hit -$0.35 (min: -$0.33, max: -$0.36).

What is ORMP's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: ORMP) forecast ROE is -9.2%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.